GENE-THERAPEUTIC DNA-VECTOR BASED ON GENE-THERAPEUTIC DNA-VECTOR VTVAF17, CARRYING TARGET GENE CAS9 FOR HETEROLOGOUS EXPRESSION OF THIS TARGET GENE IN HUMAN AND ANIMAL CELLS IN IMPLEMENTING VARIOUS METHODS OF GENOMIC EDITING, METHOD OF PRODUCING AND USING GENE-THERAPEUTIC DNA VECTOR, ESCHERICHIA COLI SCS110-AF/VTVAF17-CAS9 STRAIN, CARRYING GENE-THERAPEUTIC DNA VECTOR, METHOD FOR PREPARING THEREOF, METHOD FOR PRODUCTION ON INDUSTRIAL SCALE OF GENE-THERAPEUTIC DNA VECTOR Russian patent published in 2020 - IPC C12N15/12 C12N15/70 C12N1/21 A61K48/00 C12R1/19 

Abstract RU 2730663 C2

FIELD: biotechnology; medicine; agriculture.

SUBSTANCE: invention refers to genetic engineering and can be used in biotechnology, medicine and agriculture to develop gene therapy preparations. Presented is a gene-therapeutic DNA vector based on the gene-therapeutic DNA vector VTvaf17, carrying the target Cas9 gene for heterologous expression of this target gene in human and animal cells when implementing various methods of genomic editing. Gene-therapeutic DNA vector VTvaf17-Cas9 has the nucleotide sequence SEQ ID No. 1. Invention also discloses a method of producing said vector, use of a vector, an Escherichia coli strain carrying said vector, as well as a method of producing said vector on an industrial scale.

EFFECT: invention can be used for safe application for human and animal genetic therapy.

8 cl, 12 dwg, 14 ex

Similar patents RU2730663C2

Title Year Author Number
VTvaf17-Act1-Cas9 GENE-THERAPEUTIC DNA VECTOR BASED ON VTvaf17 GENE-THERAPEUTIC DNA VECTOR CARRYING TARGET Cas9 GENE FOR HETEROLOGOUS EXPRESSION OF THIS TARGET GENE IN PLANT CELLS DURING GENOME EDITING OF PLANTS, METHOD OF PRODUCING AND USING GENE-THERAPEUTIC DNA VECTOR, STRAIN OF ESCHERICHIA COLI SCS110-AF/VTvaf17-Act1-Cas9 CARRYING GENE-THERAPEUTIC DNA VECTOR, METHOD FOR PREPARING THEREOF, METHOD FOR INDUSTRIAL PRODUCTION OF GENE-THERAPEUTIC DNA VECTOR 2019
  • Savelieva Natalia
RU2715314C1
GENE-THERAPEUTIC DNA-VECTOR BASED ON THE GENE-THERAPEUTIC DNA-VECTOR VTVAF17, CARRYING THE TARGET GENE SELECTED FROM THE SOD1, SOD2, SOD3, CAT GENE GROUP TO INCREASE THE LEVEL OF EXPRESSION OF THESE TARGET GENES, METHOD FOR PRODUCTION AND USE THEREOF, ESCHERICHIA COLI SCS110-AF/VTVAF17-SOD1 STRAIN, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-SOD2, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-SOD3, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-CAT, CARRYING A GENE-THERAPEUTIC DNA VECTOR, A METHOD FOR PRODUCTION THEREOF, A METHOD FOR INDUSTRIAL PRODUCTION OF A GENE-THERAPEUTIC DNA VECTOR 2018
  • Savelieva Natalia
RU2731515C2
GENE-THERAPEUTIC DNA VECTOR BASED ON THE GENE-THERAPEUTIC DNA VECTOR VTvaf17, CARRYING THE TARGET GENE SELECTED FROM THE GROUP OF SKI, TGFB3, TIMP2, FMOD GENES TO INCREASE THE LEVEL OF EXPRESSION OF THESE TARGET GENES, A METHOD FOR PREPARING AND USING IT, ESCHERICHIA COLI SCS110-AF/VTvaf17-SKI STRAIN OR ESCHERICHIA COLI SCS110-AF/VTvaf17-TGFB3 OR ESCHERICHIA COLI SCS110-AF/VTvaf17-TIMP2 OR ESCHERICHIA COLI SCS110-AF/VTvaf17-FMOD, CARRYING A GENE-THERAPEUTIC DNA VECTOR, A METHOD FOR PRODUCTION THEREOF, A METHOD FOR INDUSTRIAL PRODUCTION OF A GENE-THERAPEUTIC DNA VECTOR 2018
  • Savelieva Natalia
RU2705256C1
GENE-THERAPEUTIC DNA-VECTOR BASED ON GENE-THERAPEUTIC DNA-VECTOR VTVAF17, CARRYING TARGET GENE SELECTED FROM GROUP OF GENES KRT5, KRT14, LAMB3, COL7A1, TO INCREASE LEVEL OF EXPRESSION OF THESE TARGET GENES, METHOD FOR PRODUCTION AND USE THEREOF, STRAIN ESCHERICHIA COLI SCS110-AF/VTVAF17-KRT5, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-KRT14, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-LAMB3, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-COL7A1, CARRYING GENE-THERAPEUTIC DNA VECTOR, METHOD FOR PRODUCTION THEREOF, METHOD FOR INDUSTRIAL PRODUCTION OF GENE-THERAPEUTIC DNA VECTOR 2018
  • Savelieva Natalia
RU2730667C2
GENE-THERAPEUTIC DNA-VECTOR BASED ON THE GENE-THERAPEUTIC DNA-VECTOR VTvaf17, CARRYING THE TARGET GENE SELECTED FROM THE GROUP OF GENES COL1A1, COL1A2, BMP2, BMP7, TO INCREASE THE LEVEL OF EXPRESSION OF THESE TARGET GENES, METHOD FOR PRODUCTION AND USE THEREOF, ESCHERICHIA COLI SCS110-AF/VTvaf17-COL1A1 STRAIN OR ESCHERICHIA COLI SCS110-AF/VTvaf17-COL1A2 OR ESCHERICHIA COLI SCS110-AF/VTvaf17-BMP2 OR ESCHERICHIA COLI SCS110-AF/VTvaf17-BMP7, CARRYING A GENE-THERAPEUTIC DNA VECTOR, METHOD FOR PRODUCTION THEREOF, A METHOD FOR INDUSTRIAL PRODUCTION OF A GENE-THERAPEUTIC DNA-VECTOR 2018
  • Savelieva Natalia
  • Lazarev Vasilij Nikolaevich
  • Shmarina Galina Vasilevna
RU2707537C1
GENE-THERAPEUTIC DNA-VECTOR BASED ON GENE-THERAPEUTIC DNA-VECTOR VTVAF17, CARRYING TARGET GENE SELECTED FROM SHH, CTNNB1, NOG, WNT7A GENE GROUP TO INCREASE LEVEL OF EXPRESSION OF THESE TARGET GENES, METHOD FOR PRODUCTION AND USE THEREOF, STRAIN ESCHERICHIA COLI SCS110-AF/VTVAF17-SHH, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-CTNNB1, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-NOG, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-WNT7A, CARRYING GENE-THERAPEUTIC DNA VECTOR, METHOD FOR PRODUCTION THEREOF, METHOD FOR INDUSTRIAL PRODUCTION OF GENE-THERAPEUTIC DNA VECTOR 2018
  • Savelieva Natalia
RU2731514C2
GENE-THERAPEUTIC DNA-VECTOR BASED ON GENE-THERAPEUTIC DNA-VECTOR VTVAF17, CARRYING TARGET GENE SELECTED FROM GROUP OF GENES COL1A1, COL1A2, P4HA1, P4HA2, COL7A1, CLCA2, ELN, PLOD1 TO INCREASE LEVEL OF EXPRESSION OF SAID TARGET GENES, METHOD FOR PRODUCTION AND USE THEREOF, STRAIN ESCHERICHIA COLI SCS110-AF/VTVAF17-COL1A1, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-COL1A2, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-P4HA1, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-P4HA2, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-COL7A1, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-CLCA2, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-ELN, OR ESCHERICHIA COLI SCS110-AF/VTVAF17- PLOD1, CARRYING GENE-THERAPEUTIC DNA VECTOR, METHOD FOR PRODUCTION THEREOF, METHOD FOR INDUSTRIAL PRODUCTION OF GENE-THERAPEUTIC DNA VECTOR 2018
  • Savelieva Natalia
RU2730661C2
GENE THERAPY DNA VECTOR BASED ON GENE THERAPY DNA VECTOR VTvaf17 CARRYING A TARGET GENE SELECTED FROM THE GROUP OF OPG, PDGFA, PDGFB GENES TO INCREASE THE LEVEL OF EXPRESSION OF THESE TARGET GENES, METHOD FOR ITS PREPARATION AND USE, STRAIN ESCHERICHIA COLI SCS110-AF/VTvaf17-OPG, OR ESCHERICHIA COLI SCS110-AF/VTvaf17-PDGFA, OR ESCHERICHIA COLI SCS110-AF/VTvaf17-PDGFB, CARRYING GENE THERAPY DNA VECTOR, METHOD FOR ITS PRODUCTION, METHOD FOR INDUSTRIAL SCALE PRODUCTION OF GENE THERAPY DNA VECTOR 2018
  • Savelieva Natalia
RU2771961C2
GENE-THERAPY DNA-VECTOR BASED ON GENE-THERAPY DNA-VECTOR VTVAF17, CARRYING TARGET GENE SELECTED FROM GROUP OF GENES IL11, LIF, DICER, HOXA10, WT1, TO INCREASE EXPRESSION LEVEL OF THESE TARGET GENES, METHOD FOR PRODUCTION AND USE THEREOF, STRAIN ESCHERICHIA COLI SCS110-AF/VTVAF17-IL11, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-LIF, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-DICER, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-HOXA10, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-WT1, CARRYING GENE-THERAPEUTIC DNA VECTOR, METHOD FOR PRODUCTION THEREOF, METHOD FOR INDUSTRIAL PRODUCTION OF GENE-THERAPEUTIC DNA VECTOR 2018
  • Savelieva Natalia
RU2720376C1
GENE-THERAPEUTIC DNA-VECTOR BASED ON GENE-THERAPEUTIC DNA-VECTOR VTVAF17, CARRYING TARGET GENE SELECTED FROM GROUP OF GENES ANG, ANGPT1, VEGFA, FGF1, HIF1Α, HGF, SDF1, KLK4, PDGFC, PROK1, PROK2 TO INCREASE EXPRESSION LEVEL OF SAID TARGET GENES, METHOD FOR PRODUCTION AND USE THEREOF, STRAIN ESCHERICHIA COLI SCS110-AF/VTVAF17-ANG, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-ANGPT1, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-VEGFA, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-FGF1, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-HIF1Α, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-HGF, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-SDF1, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-KLK4, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-PDGFC, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-PROK1, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-PROK2, CARRYING GENE-THERAPEUTIC DNA VECTOR, METHOD FOR PRODUCTION THEREOF, METHOD FOR INDUSTRIAL PRODUCTION OF GENE-THERAPEUTIC DNA VECTOR 2018
  • Savelieva Natalia
RU2730664C2

RU 2 730 663 C2

Authors

Savelieva Natalia

Dates

2020-08-24Published

2018-12-27Filed